Life Science Nation Newsletter  |  March 19, 2015  |  Issue 103

  The LSN Story   |   Investor Platform   |   Company Platform   |   RESI Conference   |   Fundraising Accelerator
Life Science Investor Mandates (Mar. 12 - Mar. 18)

Seeking Devices and Diagnostics

Seeking Connected Device Opportunities

Seeking Therapeutics, Diagnostics and Medical Devices Throughout EU and US
Seeking Range of Therapeutics Opportunities Globally
In This Issue

Calling All Innovators! RESI Innovation Challenge: Applications Now Open for RESI@TMCx on June 8, 2015


RESI @ TMCx Medtech Angels Panel Announcement


The Shape of A Biotech Pipeline 

RESI Conference Group's Upcoming Events
LSN Videos
RESI 4 Recap Video, San Francisco, 2015
RESI 4 Investor Panel Videos
 Fundraising Boot Camp 
Calling All Innovators! RESI Innovation Challenge: Applications Now Open for RESI@TMCx on June 8, 2015
By Jack Fuller, Director of Business Development, LSN
Shaoyu Chang, MD, MPH, Senior Research Analyst, LSN


LSN and the Texas Medical Center have partnered to bring the Redefining Early Stage Investments Conference (RESI) to the emerging life science hub of the American Southwest-Houston, TX-on June 8, 2015. We are proud to announce an open call for applications to the RESI Innovation Challenge. Presenting life science companies will have the chance to showcase their innovations to RESI's audience at the Texas Medical Center's new life science accelerator TMCx.

If you are a scientist-entrepreneur or fundraising CEO starting to accumulate compelling proof-of-concept animal data or early stage clinical data, the RESI Innovation Challenge is for you. The 30 most innovative applicants will be hand selected by Life Science Nation's internal scientific review board to be part of the RESI Innovation Challenge, presenting their technologies in an exhibition-style format throughout the full-day conference. Presenters will gain additional exposure to investors and potential partners by showcasing their companies and products in a poster format...
RESI @ TMCx Medtech Angels Panel Announcement
By Michael Quigley, Director of Research, LSN

Angels represent an extremely important pool of capital for a fundraising entrepreneur, especially since they have been increasingly syndicating and participating in larger financing rounds. To help entrepreneurs with a medical device or technology better understand how to receive an allocation from an angel, LSN has assembled a panel of angel investors with specific interested in medical technology.

Moderated by Richard Koffler, Member, Tech Coast Angels, the audience will hear from:
  • Ashok Rao, Member , GOOSE Society of Texas
  • Chuck McCoy, Founder and Executive Director, North Texas Angel Network
  • Philip Sanger, Managing Partner, Texo Ventures
  • Robert Tucci, Co-Chair, Sciences and Life Sciences, Houston Angel Network
The Shape of A Biotech Pipeline

By Lucy Parkinson, Senior Research Manager, LSN 


In our recent explorations of the life science innovation landscape in various areas of the U.S., we've looked at how different regions shape up in terms of pipeline assets, key indication areas, and the kind of investors active in each region. One metric in which we saw substantial distinctions is where assets fall in the pipeline. Not every area with an abundance of preclinical assets also has a large amount of Phase III assets that may become marketed products in the near future.


The LSN Company Platform tracks over 30,000 life science companies globally.  From this data, we took a sample of the asset distribution in five states with substantial biotech pipelines: California, Massachusetts, New York, New Jersey, and Maryland (see Figure 1). This data reveals patterns that challenge key assumptions about what a regional biotech pipeline looks like.